Preferred Label : Reluscovtogene Ralaplasmid;
NCIt definition : A vaccine consisting of DNA plasmid encoding the severe acute respiratory syndrome-coronavirus
2 (SARS-CoV-2) surface antigen spike (S) protein, with potential immunizing activity
against SARS-CoV-2. Upon administration of reluscovtogene ralaplasmid via intradermal
(ID) injection followed by electroporation (EP), the DNA plasmids enter the cells
and the cells produce the SARS-CoV-2 S protein. This may activate both humoral and
cellular immune responses which may result in protection against SARS-CoV-2 infection.;
UNII : 5Y0I0UU2IT;
CAS number : 2416305-96-7; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 2416305-96-7
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;
Molecule name : INO 4800; INO-4800; pGX-9501; pGX 9501;
NCI Metathesaurus CUI : CL1406616;
Origin ID : C172734;
UMLS CUI : C5446354;
Semantic type(s)
- UMLS correspondences (same concept)
- concept_is_in_subset
